MRTX News and Press, Mirati Therapeutics Inc. From 11/02/23

SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, and Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial-stage targeted oncology com...

2023-10-31 05:37:44 ET Related stories: Bristol-Myers Squibb Company (BMY) Q3 2023 Earnings Call Transcript Bristol-Myers Squibb Company 2023 Q3 - Results - Earnings Call Presentation Bristol-Myers Squibb Acquisition Of Mirati Makes Sense EMA validates Bristo...

NEW YORK, NY / ACCESSWIRE / October 28, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Mirati Therapeutics, Inc. (NASD...

2023-10-24 11:43:43 ET More on Mirati Therapeutics Mirati Therapeutics: Anatomy Of A Long Simmering Buyout Bristol-Myers' Mirati Takeover: Pharma Is Either Buying Crown Jewels Or A Dud Mirati: Expansion Of Adagrasib With sNDA And Combination Studies Will more...

2023-10-23 18:26:00 ET Summary We are circling back on clinical stage developmental concern Tango Therapeutics, Inc. for the first time since November 2022. The company recently raised capital to fund all operations well into 2027, and a beneficial owner/director just added just o...

MONSEY, N.Y., Oct. 20, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Mirati Therapeutics, Inc. (Nasdaq: MRTX) (“Mirati”) to Bristol Myers Squibb (“Bristol Myers”) for $58.00 per share in cash, plu...

Mirati Presents Late-Breaking Results Evaluating the Combination of Adagrasib and Pembrolizumab in First-Line Non-Small Cell Lung Cancer (NSCLC) PR Newswire SAN DIEGO , Oct. 17, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc. ® (NASDAQ: MRTX), a comme...

2023-10-13 15:00:54 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...

2023-10-13 11:20:21 ET More on Tango Therapeutics Tango Stock Surges On Peer Data Merits Excitement And Perspective Tango Therapeutics: Partial Phase 1 Data Has Not Helped Seeking Alpha’s Quant Rating on Tango Therapeutics Historical earnings data for ...

2023-10-10 07:30:00 ET Summary After years of buyout rumors, Mirati has finally received a buyout offer. The offer from Bristol-Myers Squibb was disappointing to shareholders who were anticipating a significant buyout premium. Although there is always a possibility of addition...